financetom
Business
financetom
/
Business
/
Kits Eyecare reports preliminary Q2 revenue, beats estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Kits Eyecare reports preliminary Q2 revenue, beats estimates
Jul 7, 2025 4:46 AM

Overview

* Kits Eyecare ( KTYCF ) Q2 preliminary revenue grows 31% yr/yr, beating analyst expectations

* Adjusted EBITDA for Q2 exceeds 5% of revenue

* Co says cash position remains "strong" at over C$18 mln

Result Drivers

* REVENUE GROWTH - Revenue increased 31% year-over-year to C$49.6 million, exceeding analyst expectations

* CUSTOMER ACQUISITION - New customers increased by 55% year-over-year, indicating effective growth strategies

* STRONG CASH POSITION - Maintained a strong cash position of over C$18 million, reflecting financial stability

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Beat C$49.60 C$48.90

Revenue mln mln (3

Analysts

)

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Amkor Technology Insider Sold Shares Worth $315,100, According to a Recent SEC Filing
Amkor Technology Insider Sold Shares Worth $315,100, According to a Recent SEC Filing
Oct 17, 2024
04:36 PM EDT, 10/17/2024 (MT Newswires) -- Guillaume Marie Jean Rutten, Director, President and CEO, on October 15, 2024, sold 10,000 shares in Amkor Technology ( AMKR ) for $315,100. Following the Form 4 filing with the SEC, Rutten has control over a total of 204,971 shares of the company, with 204,971 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1047127/000104712724000197/xslF345X05/wk-form4_1729197230.xml ...
WD-40 Fiscal Q4 Earnings, Sales Increase; Fiscal 2025 Outlook Set
WD-40 Fiscal Q4 Earnings, Sales Increase; Fiscal 2025 Outlook Set
Oct 17, 2024
04:33 PM EDT, 10/17/2024 (MT Newswires) -- WD-40 ( WDFC ) reported fiscal Q4 earnings late Thursday of $1.23 per diluted share, up from $1.21 a year earlier. One analyst surveyed by Capital IQ expected $1.31. Net sales for the quarter ended Aug. 31 were $156.0 million, up from $140.5 million a year earlier. One analyst surveyed by Capital IQ...
First Financial Bankshares Q3 EPS, Revenue Increase
First Financial Bankshares Q3 EPS, Revenue Increase
Oct 17, 2024
04:32 PM EDT, 10/17/2024 (MT Newswires) -- First Financial Bankshares ( FFIN ) reported Q3 earnings Thursday of $0.39 per diluted share, up from $0.35 a year earlier. Analysts polled by Capital IQ expected $0.39. Revenue for the quarter ended Sept. 30, expressed as the sum of net interest income and total noninterest income, was $139.5 million, up from $122.2...
Procept Biorobotics Insider Sold Shares Worth $1,811,653, According to a Recent SEC Filing
Procept Biorobotics Insider Sold Shares Worth $1,811,653, According to a Recent SEC Filing
Oct 17, 2024
04:32 PM EDT, 10/17/2024 (MT Newswires) -- Kevin Waters, Executive Vice President, CFO, on October 15, 2024, sold 25,000 shares in Procept Biorobotics ( PRCT ) for $1,811,653. Following the Form 4 filing with the SEC, Waters has control over a total of 96,096 shares of the company, with 96,096 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1588978/000162828024043032/xslF345X05/wk-form4_1729196860.xml Price: 70.49, Change: +1.41,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved